COMPANY

SYNCHRONY PHARMA LIMITED

Name: SYNCHRONY PHARMA LIMITED peptide roles
Creator: Global Peptide Index
License: https://globalpeptideindex.com/methodology

SYNCHRONY PHARMA LIMITED: marketing authorisation holder for Icatibant, as stated by public registers.

MARKETING AUTHORISATION HOLDER

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

Icatibant	ICATIBANT 30 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE, PL 39280/0034, Authorised Regulator MHRA

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.